|
|
||||||||
Experimental Studies |
1 From the Dept of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, AN-241, Boston, MA 02215. From the 1998 RSNA scientific assembly. Received Aug 26, 1998; revision requested Oct 22; revision received Feb 18, 1999; accepted Jul 1. Q.C. supported by Scientist Development Grant from the American Heart Association and Genentech. R.R.E. supported in part by grant R01HL57437 from National Institutes of Health and the Lauterbur Award from the Society of Computed Body Tomography and Magnetic Resonance. M.M. supported in part by 1996 RSNA seed grant. Address reprint requests to Q.C. (e-mail: qchen@caregroup.harvard.edu).
| Abstract |
|---|
|
|
|---|
MATERIALS AND METHODS: Airway obstruction was created by inflating a 5-F balloon catheter into a secondary bronchus. Pulmonary emboli were created by injecting thrombi into the inferior vena cava. Regional pulmonary ventilation was assessed with 100% oxygen as a T1 contrast agent. Regional pulmonary perfusion was assessed with a two-dimensional fast low-angle shot, or FLASH, sequence with short repetition and echo times after intravenous administration of gadopentetate dimeglumine.
RESULTS: Matched ventilation and perfusion abnormalities were identified in all animals with airway obstruction. MR perfusion defects without ventilation abnormalities were seen in all animals with pulmonary emboli.
CONCLUSION: Ventilation and perfusion MR imaging are able to provide regional pulmonary functional information with high spatial and temporal resolution. The ability of MR imaging to assess both the magnitude and regional distribution of pulmonary functional impairment could have an important effect on the evaluation of lung disease.
Index terms: Bronchi, stenosis or obstruction, 671.90 Embolism, experimental studies, 60.72 Gadolinium Lung, MR, 60.121411, 60.121413, 60.12143 Lung, perfusion Lung, ventilation Oxygen
| Introduction |
|---|
|
|
|---|
Berthezene et al (1) demonstrated the feasibility of magnetic resonance (MR) ventilation imaging in a rat model with aerosolized gadopentetate dimeglumine as a contrast agent. Combined with gadopentetate dimeglumineenhanced perfusion imaging, their results showed that MR imaging is able to demonstrate regional pulmonary ventilation and perfusion. However, gadopentetate dimeglumine is not approved by the U.S. Food and Drug Administration in the form of an inhaled aerosol; thus, this approach is not available in clinical settings. Recently, hyperpolarized gases such as helium 3 and xenon 129 have been used for MR ventilation imaging (2,3). Although promising, these methods also have disadvantages. Among these are the high cost of the apparatus for gas polarization and the need for special MR imaging hardware.
We recently developed MR imaging techniques to assess pulmonary ventilation and perfusion on a regional basis. In these, oxygen is used as a T1 contrast agent to assess pulmonary ventilation (4,5), and a bolus of gadopentetate dimeglumine is used to assess pulmonary perfusion (6,7). These methods not only obviate radioactive substances but also result in images with better spatial and temporal resolution than are achieved with radionuclide scintigraphy. Moreover, since oxygen is readily available and intravenous gadopentetate dimeglumine is currently in routine use, implementation of these techniques in a clinical setting is a straightforward process.
The purpose of this study was to evaluate these methods in the assessment of regional pulmonary ventilation and perfusion with pig models of airway obstruction and pulmonary embolism.
| MATERIALS AND METHODS |
|---|
|
|
|---|
MR Imaging Techniques
Ventilation imaging.Regional ventilation was assessed with oxygen as a T1 contrast agent. T1-weighted coronal images were acquired with an inversion-recovery single-shot turbo spin-echo sequence while the animals received mechanical ventilation alternately with either room air or 100% oxygen. Centrically reordered phase encoding was used to produce high signal-to-noise ratio (5). The observed signal intensity (SI) change in the lung results from the shortening of the proton spin-lattice relaxation time (T1) in the lung tissue and blood, owing to the paramagnetic effect of molecular oxygen (4). The spin-echo nature of the sequence minimizes the sensitivity to field inhomogeneities within the lung tissue. The short interecho spacing reduces the duration of the data collection (approximately 538 msec for a 128 x 256 matrix), making it relatively insensitive to respiratory motion artifacts. Imaging parameters included the following: repetition time msec/echo time (effective) msec of 5,000/4.2, matrix of 128 x 256, interecho time of 4.2 msec, readout bandwidth of 650 Hz per pixel, section thickness of 812 mm, and field of view of 3540 x 3540 cm. To obtain the maximal SI difference between the ventilation of room air and oxygen, the delay time, or inversion time, between the inversion pulse and the beginning of data acquisition was adjusted from 600 to 1,100 msec at a 100-msec interval. One posterior section location was used for this process, which took approximately 5 minutes to complete. The inversion time determined with this process was then used for the rest of the study.
Perfusion imaging.Pulmonary perfusion was assessed with a two-dimensional fast low-angle shot (FLASH) (8) MR sequence with short repetition and echo times after the intravenous administration of a T1-shortening contrast agent, gadopentetate dimeglumine (Magnevist; Berlex Laboratories, Wayne, NJ). A short echo time was used to overcome the SI loss owing to the short T2* of lung tissue. Ten milliliters of gadopentetate dimeglumine was administered as a 4-second intravenous bolus. The bolus was synchronized to the start of the two-dimensional dynamic FLASH sequence. Data for five to six coronal sections were acquired at 2.03.5-second intervals for 6075 seconds. Sequence parameters included the following: 3.0/0.9 with flip angle of 25°, readout bandwidth of 976 Hz per pixel, 812-mm section thickness, 128 x 128 matrix, and field of view of 3540 x 3540 cm.
Anatomic imaging.T2-weighted coronal images were obtained with a standard half-Fourier rapid acquisition with relaxation enhancement (RARE) sequence (HASTE; Siemens) (3,000 [effective]/43 [effective]). T1-weighted coronal images were acquired with an inversion-recovery single-shot turbo spin-echo sequence (5,000 [effective]/4.2 [effective]/600 [inversion time msec]). Intermediate-weighted coronal images were acquired with a centrically reordered single-shot turbo spin-echo sequence (5,000 [effective]/4.2 [effective]). These images were used for comparison with the ventilation and perfusion MR images. Other imaging parameters for all three sequences were section thickness of 812 mm, field of view of 3540 x 3540 cm, matrix of 128 x 256, interecho time of 4.2 msec, readout bandwidth of 650 Hz per pixel.
Animal Models
Airway occlusion model.Seven Yorkshire pigs (2330 kg) were studied. Animals were anesthetized (preanesthesia with ketamine hydrochloride 20 mg per kilogram of body weight, xylazine hydrochloride 2 mg/kg, and atropine sulfate 0.04 mg/kg), intubated, and allowed to breathe either room air or 100% oxygen. An arterial catheter was placed for blood pressure and blood gas monitoring. Airway obstruction was created by placing a 5-F balloon catheter (Medi-tech/Boston Scientific, Watertown, Mass) in a secondary bronchus with fluoroscopic guidance. The balloon was inflated with 3% iodinated contrast agent for better visualization during placement of the balloon. The animals were then immediately transported from the animal preparation facility to the MR imaging suite. The experiment with pig 4 was postponed for 1
hours owing to technical problems with the MR imaging system. This delay led to postobstructive collapse. Data from this animal were presented separately and compared with that from the other six animals.
Pulmonary embolism model.Six Yorkshire pigs (2427 kg) were studied. Animals were anesthetized (ketamine hydrochloride 20 mg/kg, xylazine hydrochloride 2 mg/kg, and atropine sulfate 0.04 mg/kg), intubated, and ventilated with either room air or 100% oxygen. A 14-F sheath was introduced into the common femoral vein as a conduit for the clot. A catheter was also inserted into the common femoral artery to allow monitoring of oxygenation, pulse rate, and blood pressure. Five milliliters of blood was drawn from the femoral vein. Thrombi, histologically similar to those formed in vivo, were first produced in a modified Chandler device (9). The thrombi were cut into small pieces, 8 mm in diameter and 15 mm long, to approximate small emboli. The clots were then flushed through the sheath and into the inferior vena cava with saline solution. After that, the animals were transported from the animal preparation facility to the MR imaging suite for experiments.
Image Analysis
Ventilation imaging.Forty to 80 coronal images were acquired per section while the pigs were ventilated alternately with room air and 100% oxygen. Ventilation maps were created as the difference in SI between the oxygen-enhanced and room-air images. The SI in the difference map was calculated for each pixel as SI = SIpost - SIpre, where SIpre represents the averaged SI from images acquired during ventilation of room air and SIpost represents the averaged SI from images acquired during 100% oxygen. The SI difference-to-noise ratio was measured as (SIpost - SIpre)/
n, where
n is the SD of background noise in the subtracted image. Dynamic SI changes versus time were plotted for regions of interest (ROIs) placed (D.L.L., D.K.) in the normal and abnormal lungs. Normal lung was identified as regions with uniform SI enhancement and abnormal lung as regions with no or little enhancement. The percentage SI enhancement was calculated as (SIpost - SIpre)/SIpre x 100 in both normal and abnormal lungs.
Perfusion imaging.Twenty-four to 36 coronal images were acquired after the bolus injection of gadopentetate dimeglumine. The image with peak SI enhancement in normal lung tissues was selected to show the contrast between the normal and abnormal lungs. The time course of SI enhancement was determined from the set of images with analysis software (OSIRIS,version 3.1; University Hospital of Geneva, Switzerland). With this software, the SI of any pixel can be evaluated for the set of images obtained. SI versus time was plotted for ROIs placed (D.L.L., D.K.) in the normal and abnormal regions of lung. The percentage SI enhancement in both normal and abnormal lung was calculated as (SIpost - SIpre)/SIpre x 100, where SIpre was obtained from a selected ROI on one of the images acquired before the arrival of contrast agent and SIpost from the image that showed maximum SI enhancement in the normal lung tissues.
Ex Vivo Pulmonary Angiography and Pathologic Evaluation
Ex vivo pulmonary angiography was performed to depict the filling defects in pulmonary arteries and perfusion deficits distal to the emboli, which were later compared (D.L.L., D.K. in consensus) with those findings from MR imaging. Pulmonary angiography was performed after thoracotomy, with removal of the heart and lungs. The clamped pulmonary artery was injected with a 15-mL solution of diatrizoate sodium and radiographed in the anteroposterior plane and both oblique planes. Pathologic sectioning of the lung was used to confirm the existence of pulmonary emboli. Each lobe was carefully removed from the hilum and sectioned at 3-mm intervals, transverse to the orientation of the bronchi and arteries. The presence and location of the clots were documented.
| RESULTS |
|---|
|
|
|---|
Results from one of the six pigs without postobstructive atelectasis are shown in Figures 13. In this animal, the right lower lobe bronchus was obstructed by using an occlusion balloon (Fig 1a). The T1- and T2-weighted images did not reveal any abnormality (Fig 1). However, a ventilation defect distal to the occluded bronchus was readily detected (Fig 2a) as was a matched perfusion defect due to hypoxic vasoconstriction (Fig 2b). No oxygen-related SI change was detected in the region distal to the obstruction, whereas substantial SI change was observed in other portions of the lung (Fig 3a). Decreased perfusion SI was also clearly seen in the abnormal region in comparison with normal regions (Fig 3b).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The use of MR imaging for the evaluation of pulmonary disease has been limited. The unique composition of lung tissue makes it one of the most difficult organs to evaluate with MR imaging. Little or no SI can be detected with conventional spin-echo or gradient-echo sequences owing to the low proton density of the lung. Additionally, local magnetic field gradients around the air-filled alveoli rapidly dephase transverse magnetization, which leads to SI loss (12). Cardiac and respiratory motion also create artifacts with conventional MR imaging techniques. To image the lung successfully, new approaches are needed to address these issues.
One approach is the use of inhaled 129Xe or 3He for ventilation MR imaging (13,14). These noble gases can be hyperpolarized by using optical pumping techniques prior to MR studies. MR SI from these noble gases may be increased by 100,000 times compared with that in a thermal equilibrium state. Such strong SI provides the means for direct data acquisition with the inhaled gases, thus making lung imaging of the airways possible. Excellent results have been achieved in both animal and human studies (1519). Although highly promising, these methods also have disadvantages. Among them are the high cost of the apparatus for gas polarization and the need for special MR imaging hardware. Furthermore, to our knowledge, the administration of these gases in severely ill patients has not been evaluated for safety.
We have taken a different approach for functional MR imaging of the lung. We addressed the fundamental difficulties of lung imaging by developing new imaging techniques that are fast, have high signal-to-noise ratio, and are insensitive to local magnetic field inhomogeneities. For example, the use of a single-shot turbo spin-echo sequence for ventilation MR imaging greatly reduces the effect of local magnetic field inhomogeneity and motion artifacts (5,20). Similarly, the use of FLASH sequences with short echo time (0.9 msec) for perfusion MR imaging overcomes the short T2* of lung tissue (7). By implementing these MR techniques, we have accomplished pulmonary ventilation and perfusion MR imaging with oxygen and gadopentetate dimeglumine, respectively, as contrast agents (47).
The perfusion sequence balances temporal resolution with the amount of lung imaged. For example, a temporal resolution of less than 300 msec can be obtained for a single-section acquisition. However, the current study used a multisection acquisition with a temporal resolution of 23 seconds for any given section. The overall coverage of 60 mm in the coronal plane was sufficient to image the majority of the lung in the animal models. Greater coverage could be obtained, if necessary, by means of further reduction in temporal resolution or administration of additional contrast material. The duration of the sequence was sufficient to allow evaluation of both the first pass of contrast medium and recirculation.
The centrically reordered phase-encoding scheme in ventilation MR imaging greatly improved signal-to-noise ratio. A 2.5-fold increase in signal-to-noise ratio is observed when images obtained with this technique were compared to those obtained with the regular half-Fourier RARE sequence (21). The short effective time of 4.2 msec resulted from the centric-reordering method, which maximized the signal contribution from tissue with short T2 in the lung. However, this is at the expense of image quality and spatial resolution. First, the discontinuity of MR signals at the center of k space causes image blurring. Second, owing to the long acquisition time for each image (538 msec) and short T2 values in the lung, the later echoes are basically noise. When these echoes are placed at the outer k space, high-spatial-resolution information is lost. These issues should be addressed in future studies.
Findings in the current study clearly demonstrate the ability of MR imaging to depict both regional pulmonary ventilation and perfusion. In the model of airway occlusion, a mean 11-fold increase in ventilation SI enhancement was seen in the normal lung compared with that in the obstructed lung. This suggests that the use of oxygen as an MR contrast agent is a sensitive method for the evaluation of regional ventilation impairment. In the same experiment, MR perfusion imaging showed an associated decrease in perfusion SI enhancement in the obstructed lung. This likely reflects hypoxic vasoconstriction. The ability to image basic functions of the lung with this precision is promising.
The current study evaluated changes in ventilation associated with the occlusion of large airways. The ability of this technique to demonstrate smaller regions of nonventilated lung has not yet been tested. However, both the spatial and contrast resolutions of this technique appear to be sufficient to allow imaging of smaller regions of airway obstruction. Although the ventilation images were obtained in mechanically ventilated animals, the same sequence has been used successfully in healthy volunteers and patients, with a face mask and oxygen flow rates of 1015 L/min (4,5).
In the model of pulmonary embolism, mismatched ventilation and perfusion patterns were observed in all animals. Perfusion defects were seen in regions distal to the thrombi, whereas no ventilation abnormalities were detected in any animals. The application of ventilation-perfusion MR imaging to the assessment of pulmonary embolism in the current study was based on the concept developed in nuclear medicine that the overall diagnostic accuracy of radionuclide scintigraphy is substantially improved when findings from ventilation studies are combined with those from perfusion studies (22). Mismatched ventilation-perfusion abnormalities (reduced perfusion with normal ventilation) suggest a high likelihood of pulmonary embolism, whereas perfusion defects accompanied by abnormal ventilation are unlikely to represent pulmonary emboli. This was seen in the model of airway occlusion, in which perfusion abnormalities were identified that were not related to a vascular origin. This concept has also been applied recently to a rat model of pulmonary embolism with MR imaging by Berthezene et al (1). In their study, pulmonary ventilation was assessed with aerosolized gadopentetate dimeglumine as a T1 contrast agent, and pulmonary perfusion was assessed with intravenous administration of polylysine-(gadopentetate dimeglumine) 40. Their results confirm that simultaneous assessment of ventilation and perfusion improved the specificity of contrast materialenhanced perfusion MR imaging.Practical applications: MR ventilation and perfusion imaging may have a major impact on the evaluation of a variety of pulmonary disorders. Although the methods in this study were used to evaluate animal models of disease, we have used these same techniques to evaluate ventilation and perfusion in human volunteers and patients (4,5,23). The evaluation of pulmonary embolism with MR perfusion and ventilation techniques has been used on a limited basis at our institution. Combined with pulmonary MR angiography, the methods can demonstrate both perfusion defects and the accompanying emboli. In the animal models, segmental and subsegmental perfusion defects were clearly identified. Whether MR perfusion techniques will allow accurate assessment of subsegmental emboli in patients will require further study. Additionally, difficulties may arise from the presence of concomitant lung disease. As seen in the current study, the presence of atelectatic lung altered the SI of the parenchyma. Whether this will reduce the detection of small emboli will need to be evaluated in a clinical setting. The use of blood-pool MR contrast agents may further improve detection of small emboli by increasing the contrast between the intravascular space and the pulmonary interstitium. The value of these techniques in other pulmonary disorders is unknown. Clearly, alterations in regional pulmonary ventilation and perfusion play a major role in the development of hypoxemia associated with pulmonary disease (24). Studies are currently underway to examine the clinical value of these techniques in patients with various pulmonary diseases, such as pulmonary emphysema.
In conclusion, our results show that it is feasible to use MR imaging to evaluate lung function on a regional basis. This ability to demonstrate differences in regional lung function in the absence of a structural abnormality may provide an important tool for the evaluation of patients with pulmonary disease and may eventually provide quantitative regional indexes of lung function.
| Footnotes |
|---|
Author contributions: Guarantors of integrity of entire study, Q.C., R.R.E.; study concepts, Q.C., D.L.L., D.K., V.D., R.R.E.; study design, Q.C., D.K., M.M.; definition of intellectual content, Q.C., D.L.L., V.D., P.M.J., H.H.; literature research, Q.C.; experimental studies, Q.C., P.M.J., V.C., D.K., M.M., J.W.G.; data acquisition, Q.C., V.C., M.M., D.K.; data analysis, Q.C., V.C., M.A.G., J.W.G.; statistical analysis, Q.C., P.M.J., M.A.G.; manuscript preparation and editing, Q.C., D.L.L.; manuscript review, Q.C., D.L.L., D.K., V.D., M.M., P.M.J., M.A.G., J.W.G., H.H., R.R.E.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Ohno, H. Hatabu, T. Higashino, M. Nogami, D. Takenaka, H. Watanabe, M. Van Cauteren, M. Yoshimura, M. Satouchi, Y. Nishimura, et al. Oxygen-enhanced MR Imaging: Correlation with Postsurgical Lung Function in Patients with Lung Cancer Radiology, August 1, 2005; 236(2): 704 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Vidal Melo, D. Layfield, R. S. Harris, K. O'Neill, G. Musch, T. Richter, T. Winkler, A. J. Fischman, and J. G. Venegas Quantification of Regional Ventilation-Perfusion Ratios with PET J. Nucl. Med., December 1, 2003; 44(12): 1982 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suga, Y. Yuan, N. Ogasawara, T. Tsukuda, and N. Matsunaga Altered Clearance of Gadolinium Diethylenetriaminepentaacetic Acid Aerosol from Bleomycin-injured Dog Lungs: Initial Observations Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1704 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Biederer and M. Heller Artificial Thorax for MR Imaging Studies in Porcine Heart-Lung Preparations Radiology, January 1, 2003; 226(1): 250 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suga, N. Ogasawara, M. Okada, T. Tsukuda, N. Matsunaga, and M. Miyazaki Lung perfusion impairments in pulmonary embolic and airway obstruction with noncontrast MR imaging J Appl Physiol, June 1, 2002; 92(6): 2439 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ohno, H. Hatabu, D. Takenaka, S. Adachi, M. Van Cauteren, and K. Sugimura Oxygen-Enhanced MR Ventilation Imaging of the Lung: Preliminary Clinical Experience in 25 Subjects Am. J. Roentgenol., July 1, 2001; 177(1): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.U. Kauczor, X.J. Chen, E.J.R. van Beek, and W.G. Schreiber Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application Eur. Respir. J., May 1, 2001; 17(5): 1008 - 1023. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||